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Introduction
 The Association of Southeast Asian Nations (ASEAN) 
is a geopolitical and economic organisation of ten 
independent countries located in Southeast Asia: Brunei, 
Cambodia, Indonesia, Laos, Malaysia, Myanmar, the 
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Abstract
 This paper presents the most recent data on cancer rates and the burden of cancer in the ASEAN region. 
Epidemiological data were sourced from GLOBOCAN 2008 and disability adjusted life years (DALYs) lost were 
estimated using the standard methodology developed within the World Health Organization’s Global Burden of 
Disease study. Overall, it was estimated there were over 700,000 new cases of cancer and 500,000 cancer deaths 
in ASEAN in the year 2008, leading to approximately 7.5 million DALYs lost in one year. The most commonly 
diagnosed cancers were lung (98,143), breast (86,842) and liver cancers (74,777). The most common causes of 
cancer death were lung cancer (85,772), liver cancer (69,115) and colorectal cancer (44,280). The burden of cancer 
in terms of DALYs lost was highest in Laos, Viet Nam and Myanmar and lowest in Brunei, Singapore and the 
Philippines. Significant differences in the patterns of cancer from country to country were observed. Another key 
finding was the major impact played by population age distribution on cancer incidence and mortality. Cancer 
rates in ASEAN are expected to increase with ageing of populations and changes in lifestyles associated with 
economic development. Therefore, ASEAN member countries are strongly encouraged to put in place cancer-
control health care policies, focussed on strengthening the health systems to cope with projected increases in 
cancer prevention, treatment and management needs. 
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Philippines, Singapore, Thailand and Viet Nam. This 
region contains more than half a billion people, almost 
9% of the world population, spread over highly diverse 
countries, from economic powerhouses like Singapore to 
poorer economies such as Laos, Cambodia and Myanmar 
(Table 1). 
Table 1. Health and Development Indicators per ASEAN Country for 2008  
Country	 Population	GDP	per						Classification																			Life	expectancy1								Infant			Literacy	rate	(%	age	≥15)			Proportion
	 	 	estimate	 			capita		 												by	the		 																Female	 Male							mortality	 		Males						Females								<20	 						≥65	
               (in millions) (US$)         Worldbank                                              per 1000 live births           years of age
Source       UN  World Bank                    WHO*  WHO*  WHO*         UNESCO           UNESCO  
Brunei	 0.4	 43,751	 High	income	 77	 75	 3	 97	 94	 36	 3
Cambodia	 14.5	 741	 Low	income	 64	 59	 31	 85	 71	 47	 3
Indonesia	 225.9	 2,180	 Lower	middle	income	 69	 66	 19	 95	 89	 37	 6
Laos	 6.2	 829	 Low	income	 63	 61	 20	 83	 63	 50	 4
Malaysia	 26.8	 7,866	 Upper	middle	income	 76	 71	 3	 95	 90	 40	 5
Myanmar	 49.4	 233	 Low	income	 56	 53	 48	 95	 90	 37	 5
Philippines	 89.6	 1,907	 Lower	middle	income	 74	 67	 15	 95	 96	 45	 4
Singapore	 4.6	 41,291	 High	income	 83	 79	 1	 98	 92	 25	 9
Thailand	 67.0	 4,098	 Upper	middle	income	 74	 66	 10	 96	 92	 30	 7
Vietnam	 86.6	 1,047	 Low	middle	income	 75	 70	 9	 95	 91	 37	 6 
1at birth; WHO, World Health Organization *(http://www.who.int/whosis/whostat/2010/en/); UN, United Nations (Population 
Reference	Bureau,	UN	Statistics	Division);	 IMF,	 International	Monetary	 Fund	 (http://www.imf.org/external/data.htm#data);	
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 Each year, more than 700,000 new cases of cancer 
occur	in	ASEAN	countries	and	this	number	is	expected	to	
increase (Ferlay et al., 2010). Cancer has a severe impact 
on individuals and communities. Not only does it lead to 
disability and death, its treatment costs and associated 
loss	of	 income	can	quickly	undermine	family	finances.	
Consequently, globally, as well as for the ASEAN region, 
cancer has negative implications for poverty reduction 
and economic development. The United Nations has 
recently	 identified	 the	 socioeconomic	 and	 health	 toll	
from non-communicable diseases, such as cancer, as a 
major impediment to the achievement of the Millennium 
Development Goals (United Nations Non-Governmental 
Liaison Service, 2010). 
 Information about the burden of cancer in ASEAN 
countries, in common with many other developing 
countries, is incomplete and generally has not been 
systematically reviewed for coherence and consistency. 
National mortality data for most ASEAN countries 
have	been	shown	to	be	deficient	with	significant	under-
registration	 and	misclassification.	This	 study	 aims	 to	
provide a comprehensive picture of the burden of cancer 
in ASEAN. It presents incidence and mortality data 
from	GLOBOCAN	2008	and	uses	the	Global	Burden	of	
Disease (GBD) methodology and assumptions (Murray 
and Lopez, 1997) to estimate the impact of illness in terms 
of disability adjusted life years (DALYs) lost. A burden 
of disease study such as this, combined with cost data, 
enables assessments to be made of the societal toll of 
cancer in terms of lost economic and social opportunities, 
and	comparisons	across	countries.	Such	findings	can	raise	
awareness of the scale of the cancer problem, identify 
priorities for further research and catalyse political action 
to put in place effective cancer control health care policies 
(Lancet, 2010)
Materials and Methods
 Methods developed for the Global Burden of Disease 
(GBD) Study by the World Bank and World Health 
Organization (WHO) (Murray and Lopez, 1997) were 
adapted and applied to ASEAN population health data.
 Cancer sites included in this burden of disease study 
were:	mouth	and	pharynx	(ICD-10	C00-C14),	oesophagus	
(C15),	 stomach	 (C16),	 colon	 and	 rectum	 (C18-C21),	
liver	 (C22),	 pancreas	 (C25),	 trachea,	 bronchus	 and	
lung	(C33-C34),	melanoma	(C43),	female	breast	(C50),	
cervix	uterine	(C53),	corpus	uteri	(C54-55),	ovary	(C56),	
prostate	(C61),	bladder	(C67),	lymphomas	and	multiple	
myeloma	 (C81-C90,	C96),	 leukaemia	 (C91-C95),	 and	
other malignant neoplasms (balance of ICD-10 C00-C97).
Incidence and mortality data
 The primary source of cancer incidence and mortality 
data	 was	 GLOBOCAN	 2008	 (Ferlay	 et	 al.,	 2010).	
Incidence data are derived from population-based cancer 
registries, which may cover entire national populations 
but more often cover smaller, sub-national areas, and, 
particularly in developing countries, only major cities. 
Mortality statistics in GLOBOCAN are collected and 
made available by WHO (http://www.who.int/whosis/). 
Population estimates
	 National	population	estimates	for	2008	were	extracted	
from the United Nations Population Division website 
(http://www.un.org/esa/population/). Age-standardised 
rates were calculated by utilising the WHO World 
Standard Population (Ahmad et al., 2001).
Disability adjusted life years (DALYs)
 The DALY is a combined measure of mortality and 
morbidity, calculated as the sum of years of life lost due to 
premature mortality (YLL) and years lived with disability 
(YLD). YLL lost due to cancer was estimated using the 
standard GBD approach (Murray and Lopez, 1997). The 
date of death from cancer is subtracted from the date of 
death that would have occurred had the person lived an 
average	life	expectancy.	An	annual	discount	rate	of	3%	and	
standard	life	expectancies	based	on	the	West	model	levels	
25	and	26	were	used;	that	is,	males	are	expected	to	live	up	
to	the	age	of	80	and	females	up	to	the	age	of	82.5	(Coale	
and	Demeny,	1966).	We	did	not	apply	the	controversial	
non-uniform age weighting (adjustments which result in 
less weight given to years lived at young and older ages) 
which was used in the original GBD 1990 study.
 The YLD is the disability component of the DALY 
based on non-fatal health outcomes. The YLD takes the 
severity and duration of the disability into account using 
the	basic	formula	(Mathers	et	al.,	2001):	YLD	=	I	x	DW	x	
L, where I is the number of incident cases for the reference 
period, DW is the disability weight in the range 0 – 1, and 
L is the average duration of disability (in years). 
 The basis of the YLD estimation is a model of 
disease progression developed in the Dutch burden of 
disease study (Stouthard et al., 1997). The disease model 
commences with an initial phase of diagnosis and primary 
therapy, with a duration of up to 12 months. After this 
initial	 phase,	 cancer	 cases	 are	 classified	 as	 those	who	
will and will not be cured. Those who will be cured enter 
a	phase	of	up	to	5	years	after	which	they	are	considered	
cured and have no further cancer-related disability. 
Those who will not be cured enter a phase (of variable 
length) of remission followed by a phase of disseminated 
carcinoma (lasting 12 months or less), then a terminal 
phase	(lasting	1	month)	and	death.	We	modified	the	Dutch	
model to each cancer site following methods used in the 
Australian burden of disease study (Begg et al., 2007). 
Dutch disability weights were allocated to each of the 
phases in the model (Stouthard et al., 1997). Where no 
Dutch	weights	were	available	for	a	specific	cancer	site,	
we	extrapolated	weights	based	on	the	cancer	that	it	most	
resembled. Five-year survival rates for developing and 
developed countries were obtained from a study on the 
worldwide	mortality	from	25	cancers	(Pisani	et	al.,	1999).
Results 
Cancer Incidence and Mortality
	 There	were	an	estimated	724,699	new	cancer	cases	
(excluding	 non-melanoma	 skin	 cancer)	 and	 500,439	
deaths	in	the	ASEAN	region	in	2008.	Of	all	new	cases,	
46%	were	in	males	and	54%	in	females.	However,	52%	
of deaths occurred in men. Among women, breast cancer 
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Figure 1. Cancer Incidence (Thousands) for Males and 
Females in ASEAN for 2008
Table 3. Estimated Incidence Rates (per 100,000) for All Cancers by Age, 2008  
                Brunei   Cambodia     Indonesia       Laos       Malaysia  Myanmar      Singapore   Philippines   Thailand Viet Nam 
Males	 (228)	 (5,873)	 (136,172)	 (2,735)	 (15,095)	 (27,930)	 (6,434)	 (36,409)	 (50,407)	 (55,045)
	 0-14	 9.0	 10.3	 13	 11.4	 15.0	 14.2	 16.2	 9.1	 15.0	 10.1
	 15-39	 17.7	 23.0	 26.8	 25.3	 26.9	 25.9	 27.8	 23.5	 37.8	 28.0
	 40-44	 166.7	 112.7	 84.3	 107.0	 93.4	 94.9	 93.6	 84.4	 124.5	 156.9
	 45-49	 174.1	 193.7	 140.4	 176.2	 142.9	 159.1	 149.2	 125.4	 174.1	 238.6
	 50-54	 97.6	 315.9	 232.5	 304.2	 221.5	 244.9	 262.6	 231.5	 256.8	 346.0
	 55-59	 199.4	 399.5	 377.7	 441.2	 367.4	 429.5	 456.8	 373.2	 391.3	 462.5
	 60-64	 763.4	 642.9	 539.1	 643.0	 519.5	 547.4	 748.5	 479.5	 552.6	 577.1
	 65-69	 1222.4	 769.3	 822.5	 786.2	 838.2	 736.9	 1173.0	 622.0	 704.9	 693.6
	 70-74	 1090.2	 1016.8	 1003.4	 1012.3	 1009.4	 862.1	 1635.8	 690.5	 803.0	 816.2
	 75+	 2250.3	 1094.4	 1269.9	 1091.2	 1112.3	 1055.2	 2456.5	 824.2	 1080.2	 1057.0
 All ages 112.5 82.5 120.0 88.4 110.0 115.3 277.3 80.0 152.0 128.1
Females	 (185)	 (6,988)	 (156,457)	 (2,993)	 (15,095)	 (38,793)	 (6,482)	 (36,409)	 (62,259)	 (56,536)
	 0-14	 5.8	 8.0	 10.9	 9.4	 12.3	 15.7	 9.4	 6.5	 12.1	 12.0
	 15-39	 26.2	 31.9	 47.0	 40.2	 42.6	 51.8	 48.2	 36.5	 49.3	 37.9
	 40-44	 94.4	 152.8	 174.8	 180.7	 179.5	 209.9	 199.9	 174.0	 196.1	 148.8
	 45-49	 210.7	 231.1	 280.5	 247.9	 276.2	 313.7	 313.3	 202.0	 285.9	 231.5
	 50-54	 380.5	 316.9	 324.0	 330.4	 346.8	 393.6	 414.4	 323.8	 396.2	 329.7
	 55-59	 286.3	 369.6	 424.2	 407.4	 455.0	 480.9	 531.7	 363.0	 459.8	 395.6
	 60-64	 821.9	 456.2	 495.9	 506.9	 499.9	 543.1	 627.1	 343.2	 573.9	 424.1
	 65-69	 819.2	 494.6	 534.9	 577.9	 582.0	 639.5	 785.0	 424.0	 582.7	 464.5
	 70-74	 1032.6	 592.2	 613.9	 698.0	 607.3	 707.7	 934.1	 424.7	 638.4	 518.6
	 75+	 757.3	 509.3	 757.6	 652.1	 657.8	 766.8	 1377.4	 575.5	 688.5	 680.2
 All ages 97.6 93.9 137.5 96.2 127.1 153.1 282.4 90.9 181.9 128.1 
(total numbers of incident cases in parentheses) 
Table 2. The Top 5 Cancer Sites in ASEAN, 2008 
                   Incidence                    Mortality
            Site Incident cases    Site    Deaths 
Males	 Lung		 66515	 Lung		 57935
	 Liver		 50817	 Liver		 46907
	 Colorectal		 34318	 Colorectal		 22152
	 Mouth		 29818	 Stomach		 20032
	 Stomach		 24899	 Mouth		 18107
Females	 Breast		 86842	 Breast		 36723
	 Cervix		 44351	 Lung		 27837
	 Colorectal		 34493	 Cervix		 22473
	 Lung		 31628	 Liver		 22208
	 Liver		 23960	 Colorectal		 22128
Overall	 Lung	 98143	 Lung	 85772
	 Breast	 86842	 Liver	 69115
	 Liver	 74777	 Colorectal	 44280
	 Colorectal	 68811	 Breast	 36724
	 Mouth	 47273	 Stomach	 35320
had the highest incidence, followed by cervical cancer and 
colorectal cancer. Among men, the three most common 
cancer sites were lung, liver, and colorectal (Figure 1). 
The most common fatal cancer in ASEAN for males 
and	 females	 combined	was	 lung	 cancer	 (98,143	 cases	
and	85,772	deaths).	The	second	most	common	was	liver	
cancer	(74,777	new	cases	and	69,115	deaths),	followed	
by	colorectal	cancer	 (68,811	cases	and	44,280	deaths).	
Table 2 illustrates that the rank order of the burden of 
disease by cancer site differs slightly when measured by 
mortality versus incidence, although the top four cancers; 
lung, liver, colorectal and breast, are the same for men and 
women combined. The major change occurs in females; 
lung cancer in females ranks fourth in terms of incidence, 
but	second	in	terms	of	mortality	in	2008.	These	differences	
in rank order of incidence and mortality by cancer site 
are	mainly	due	to	the	differing	survival	rates	of	specific	
cancers.
 Crude incidence and mortality rates for all cancer sites 
combined,	by	age	and	sex,	for	each	ASEAN	country	are	
presented in Tables 3 and 4. Among the ASEAN countries, 
the highest crude incidence rates per 100,000 for total 
cancer (all sites)  are estimated in Singapore, for both 
males	(277.3)	and	females	(282.4),	and	the	lowest	in	the	
Philippines,	also	for	both	males	(80)	and	females	(90.9).	
Singapore also has the highest crude mortality rates per 
100,000	 (148.5	 for	males	 and	 115.9	 for	 females)	 and	
the	Philippines	the	lowest	(57.3	for	males	and	49.6	for	
females). 
	 Cancer	 incidence	 increases	 significantly	with	 age	
(Figure 2). Figure 3 shows the age distribution in the 
ASEAN countries. When the effect of age is eliminated 
by age-standardisation, the difference between countries 
is	less	pronounced	(Table	5).	Singapore	still	ranks	highest	
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and Philippines lowest for incidence rates; however, the 
ranking in terms of mortality rates changes. For instance 
Singapore falls to ninth in terms of cancer mortality. 
Importantly, geographic variation was still substantial 
after	age-adjustment	and	large	differences	in	rates	exist	
when	looking	at	specific	cancer	sites	(Table	6).
The Seven Most Important Site-specific Cancers
Lung cancer
 Lung cancer was the most commonly diagnosed 
cancer, as well as the leading cause of cancer death in 
ASEAN	in	2008.	Age-standardised	mortality	rates	(per	
100,000) for males and females combined were highest 
in	Vietnam	(21.5)	and	Singapore	(21.2)	and	lowest	in	the	
Philippines (14.2) and Cambodia (14.7). In males, the 
age-standardised mortality rates were highest in Singapore 
and	Vietnam	(both	31.6)	and	lowest	in	Myanmar	(20.9)	
and	Brunei	 (19.8).	 In	 females,	Brunei	 had	 the	 highest	
mortality rate (20.2), followed by Vietnam and Laos 
(both 13.9), which were all much higher than rates in the 
Philippines	(6.4)	and	Cambodia	(8.2)	(Figure	4).	Since	the	
most important risk behaviour for lung cancer is tobacco 
smoking, the observed variations in rates and trends 
across countries, or between males and females within 
each	country,	are	thought	to	largely	reflect	differences	in	
the stage and degree of the tobacco epidemic (Youlden 
Table 4. Estimated Mortality Rates (per 100,000) for All Cancers by Age, 2008  
                Brunei   Cambodia     Indonesia       Laos        Malaysia  Myanmar      Singapore   Philippines   Thailand Viet Nam 
Males	 (114)	 (4,590)	 (110,084)	 (2,208)	 (10,917)	 (21,672)	 (3,446)	 (26,062)	 (35,484)	 (43,688)
	 0-14	 5.4	 5.7	 10.5	 6.5	 11.1	 7.5	 1.7	 4.4	 3.4	 4.5
	 15-39	 5.5	 14.7	 16.6	 15.8	 14.8	 15.8	 8.0	 15.0	 19.2	 21.6
	 40-44	 50.7	 76.3	 56.6	 76.7	 56.5	 61.3	 32.0	 58.9	 74.4	 103.0
	 45-49	 82.9	 140.1	 95.0	 131.8	 86.4	 109.9	 58.3	 82.3	 116.4	 168.6
	 50-54	 88.7	 233.8	 170.5	 230.9	 146.7	 168.3	 111.4	 155.6	 177.5	 248.8
	 55-59	 99.7	 302.0	 285.0	 346.6	 256.1	 308.8	 211.0	 257.3	 257.5	 340.5
	 60-64	 247.6	 502.0	 428.8	 525.7	 379.2	 406.3	 357.1	 343.4	 353.6	 443.6
	 65-69	 475.4	 661.9	 692.6	 662.6	 644.5	 581.3	 650.3	 459.9	 531.1	 565.2
	 70-74	 1040.6	 929.6	 906.8	 941.9	 836.0	 749.4	 969.4	 550.7	 749.4	 720.1
	 75+	 1317.2	 1251.7	 1273.8	 1178.0	 1015.7	 1119.8	 1695.8	 770.9	 940.2	 1090.5
  All ages 56.3 64.5 97.0 71.4 79.6 89.5 148.5 57.3 107.0 101.7
Females	 (119)	 (4,292)	 (105,542)	 (1,983)	 (9,213)	 (23,956)	 (2,660)	 (26,062)	 (34,850)	 (38,318)
	 0-14	 7.8	 4.9	 8.8	 5.8	 8.5	 9.9	 1.3	 3.0	 3.2	 5.6
	 15-39	 6.6	 12.2	 19.5	 14.4	 15.6	 17.4	 7.7	 12.9	 18.6	 18.5
	 40-44	 29.0	 54.6	 81.1	 70.7	 66.4	 73.1	 33.5	 74.3	 64.0	 74.2
	 45-49	 120.4	 103.4	 143.8	 119.5	 115.5	 132.5	 63.6	 83.6	 117.9	 120.7
	 50-54	 214.1	 164.1	 209.5	 192.7	 179.2	 194.9	 115.7	 147.3	 162.6	 177.8
	 55-59	 210.0	 231.1	 293.2	 278.1	 257.4	 285.6	 181.5	 195.1	 224.4	 240.0
	 60-64	 376.7	 307.5	 362.2	 372.4	 303.4	 351.7	 239.1	 217.6	 277.8	 300.8
	 65-69	 983.1	 393.0	 425.0	 490.0	 387.8	 488.8	 374.1	 299.4	 414.3	 366.1
	 70-74	 760.9	 528.5	 539.6	 670.5	 446.0	 628.8	 521.2	 326.7	 526.3	 449.0
	 75+	 837.0	 626.9	 726.3	 821.1	 544.2	 960.1	 997.4	 564.8	 799.1	 713.4
 All ages 62.8 57.7 91.8 63.7 69.3 94.5 115.9 49.6 101.8 86.8 
(total numbers of cancer deaths in parentheses) 
Figure 2. Age-Specific Incidence Rates (Per 100,000 
Population) for All Cancers, by Country, in 2008
Figure 3. Age Structure of the Total Population, by 
Country, in 2008
Figure 4. Estimated Age-Standardised Mortality 
Rates (Per 100,000 Population) for Lung Cancer, by 
Country, in 2008
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Table 5. Estimated Age-standardised Incidence Rates (per 100,000) by Site, 2008  
Cancer             Brunei    Cambodia    Indonesia       Laos       Malaysia  Myanmar      Singapore   Philippines   Thailand Viet Nam 
Males          
 Mouth1	 21.8	 16.0	 13.7	 9.5	 17.3	 13.0	 14.2	 8.0	 12.0	 8.7
	 Oesophagus	 0.5	 4.3	 1.9	 2.0	 2.6	 9.6	 3.8	 1.8	 3.3	 2.9
	 Stomach	 5.6	 15.3	 9.3	 4.7	 10.7	 13.6	 13.9	 6.1	 4.2	 24.4
	 Colorectal	 38.3	 11.8	 19.1	 9.5	 19.6	 12.2	 41.6	 10.0	 13.2	 8.7
	 Liver	 6.0	 25.8	 10.3	 48.7	 8.4	 16.5	 17.0	 16.5	 40.6	 42.3
	 Pancreas	 5.5	 1.7	 3.1	 1.3	 2.4	 1.5	 5.1	 2.3	 1.7	 0.8
 Lung2	 21.7	 26.9	 29.7	 27.2	 26.8	 22.9	 37.9	 27.9	 26.8	 37.6
 Melanoma3	 4.0	 0.8	 0.7	 0.5	 0.7	 0.2	 0.5	 0.6	 0.4	 0.6
	 Prostate	 39.0	 5.8	 10.6	 4.4	 9.2	 5.8	 20.0	 10.1	 6.5	 3.2
	 Bladder	 1.5	 3.4	 5.8	 4.6	 5.4	 5.1	 7.3	 1.8	 5.5	 1.1
 Lymphomas4	 1.3	 1.3	 2.4	 1.5	 1.7	 1.2	 2.3	 1.0	 1.8	 0.7
	 Leukaemia	 1.5	 4.4	 5.9	 4.3	 6.2	 4.6	 6.8	 4.1	 5.0	 4.6
 All 176.7 152.9 145.9 154.1 142.9 141.0 208.2 118.7 146.0 154.4
Females          
 Mouth1	 15.3	 5.9	 6.5	 7.0	 8.6	 6.9	 4.8	 4.5	 8.6	 4.6
	 Oesophagus	 4.9	 0.9	 1.2	 0.6	 1.6	 5.6	 0.7	 0.9	 0.8	 1.1
	 Stomach	 10.3	 6.3	 5.6	 3.4	 6.4	 8.8	 8.3	 3.5	 3.0	 14.6
	 Colorectal		 10.2	 7.0	 15.6	 8.4	 15.5	 12.0	 28.3	 7.3	 13.4	 9.7
	 Liver	 3.8	 7.8	 3.5	 20.7	 3.0	 6.3	 3.8	 5.1	 19.9	 18.5
	 Pancreas	 4.6	 1.3	 2.5	 1.1	 1.8	 1.3	 3.7	 1.8	 1.1	 0.7
 Lung2	 14.3	 8.8	 10.9	 15.1	 9.2	 13.8	 15.3	 7.7	 12.2	 16.4
 Melanoma3 2.4	 0.2	 0.3	 0.5	 0.4	 0.3	 0.5	 0.7	 0.5	 0.7
	 Breast	 21.4	 20.7	 36.2	 17.7	 37.0	 32.5	 59.9	 31.9	 30.7	 15.6
	 Cervix	 11.2	 27.4	 12.7	 22.1	 17.9	 26.4	 6.8	 11.7	 24.5	 11.5
	 Uterus	 13.6	 4.8	 6.1	 3.0	 5.2	 4.9	 11.1	 4.6	 4.3	 7.2
	 Ovary	 8.7	 4.4	 8.8	 5.6	 7.5	 6.8	 7.7	 5.7	 6.8	 1.9
	 Bladder	 4.9	 1.6	 1.5	 1.5	 1.4	 2.0	 1.6	 0.7	 1.6	 0.6
 Lymphomas4	 4.1	 0.7	 1.9	 1.0	 1.3	 1.0	 1.7	 0.5	 1.2	 0.7
	 Leukaemia	 1.2	 3.6	 4.6	 3.5	 4.8	 4.6	 4.5	 3.6	 4.0	 6.0
 All 153.5 123.0 144.6 140.9 145.2 164.8 188.4 115.2 156.1 127.7 
1and	oropharynx;2including trachea and bronchus; 3and other skin cancers; 4including multiple myeloma  
Table 6. Estimated Age-standardised Mortality Rates (per 100,000) by Site, 2008  
Cancer             Brunei    Cambodia    Indonesia       Laos       Malaysia  Myanmar      Singapore   Philippines   Thailand Viet Nam 
Males          
 Mouth1		 11.1	 11.5	 8.5	 6.2	 9.7	 8.5	 6.8	 5.6	 6.8	 6.6
	 Oesophagus	 0.5	 4.3	 1.8	 1.8	 2.4	 9.0	 3.1	 1.4	 2.6	 2.3
	 Stomach	 4.7	 13.4	 8.8	 3.9	 9.5	 11.1	 7.8	 4.4	 3.0	 17.5
	 Colorectal		 14.9	 7.5	 14.5	 5.8	 13.0	 7.3	 18.1	 5.5	 6.5	 4.8
	 Liver	 4.4	 25.1	 10.0	 46.8	 8.1	 15.8	 14.0	 15.4	 35.1	 39.2
	 Pancreas	 3.5	 1.6	 3.0	 1.3	 2.4	 1.4	 5.3	 2.0	 1.4	 0.7
 Lung2	 19.8	 25.3	 27.8	 25.0	 24.8	 20.9	 31.6	 22.8	 22.0	 31.6
 Melanoma3	 0.0	 0.6	 0.4	 0.4	 0.3	 0.2	 0.2	 0.3	 0.2	 0.3
	 Prostate	 6.1	 3.6	 8.0	 2.5	 5.8	 3.2	 3.9	 5.3	 2.0	 1.9
	 Bladder	 0.5	 2.0	 3.8	 2.4	 2.6	 2.5	 1.6	 0.8	 2.1	 0.5
 Lymphomas4	 0.0	 1.2	 2.2	 1.3	 1.3	 0.8	 0.7	 0.5	 1.2	 0.4
	 Leukaemia	 1.0	 4.3	 5.4	 4.2	 5.2	 4.2	 2.3	 3.4	 4.0	 3.7
 All 87.5 127.5 120.0 129.1 106.6 110.3 110.0 87.4 102.6 122.6
Females          
 Mouth1		 3.6	 4.0	 3.8	 4.5	 4.6	 4.3	 1.7	 3.2	 4.4	 3.3
	 Oesophagus	 1.6	 0.9	 1.1	 0.6	 1.5	 5.1	 0.3	 0.7	 0.6	 0.8
	 Stomach	 5.2	 5.3	 5.1	 2.9	 5.6	 7.1	 4.6	 2.7	 2.1	 11.2
	 Colorectal	 9.5	 4.3	 11.7	 5.0	 10.2	 7.0	 10.7	 3.9	 6.5	 5.1
	 Liver	 6.8	 7.5	 3.5	 19.7	 2.9	 6.0	 4.5	 4.9	 16.6	 17.3
	 Pancreas	 4.6	 1.2	 2.4	 1.0	 1.8	 1.2	 3.7	 1.6	 0.8	 0.6
 Lung2	 20.2	 8.2	 10.1	 13.9	 8.5	 12.5	 12.1	 6.4	 9.3	 13.9
 Melanoma3	 0.0	 0.2	 0.2	 0.5	 0.1	 0.2	 0.3	 0.3	 0.3	 0.3
	 Breast	 17.8	 8.0	 18.6	 6.9	 14.7	 12.2	 13.6	 11.9	 10.8	 5.7
	 Cervix	 6.2	 16.2	 7.0	 13.3	 5.6	 15.0	 3.5	 5.3	 12.8	 5.7
	 Uterus	 3.1	 1.5	 1.9	 0.9	 1.4	 1.4	 1.4	 2.2	 1.1	 3.3
	 Ovary	 9.9	 2.9	 6.6	 3.7	 5.2	 4.2	 4.2	 2.8	 4.0	 0.8
	 Bladder	 1.7	 0.9	 1.0	 0.8	 0.7	 1.0	 0.6	 0.3	 0.6	 0.3
 Lymphomas4	 4.1	 0.6	 1.6	 0.8	 1.0	 0.9	 0.4	 0.2	 0.9	 0.4
	 Leukaemia	 0.0	 3.4	 4.2	 3.3	 4.0	 4.1	 1.5	 2.9	 3.1	 4.7
 All 107.7 80.1 98.2 98.8 82.2 103.5 73.3 65.9 85.9 85.0 
1and	oropharynx;2including trachea and bronchus; 3and other skin cancers; 4including multiple myeloma  
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et	al.,	2008).	Yet,	in	less	developed	countries	other	risk	
factors, such as oral tobacco use, indoor coal smoke and 
occupational	exposure	to	carcinogens,	also	have	an	impact	
(Ezzati	et	al.,	2005).
Liver cancer
 Liver cancer is the second most common cancer in 
ASEAN and the second leading cause of cancer death. 
The highest incidence and mortality rates per 100,000 are 
found	in	Laos	(33.8	and	32.3),	Thailand	(29.7	and	25.4)	
and Vietnam (29.3 and 29.2), and the lowest in Brunei 
(5.2	and	5.4),	Malaysia	(5.7	and	5.4)	and	Indonesia	(6.7	
and	6.6)	(Figure	5).	Rates	are	more	than	twice	as	high	in	
males	as	in	females	and	survival	is	poor,	as	reflected	by	
almost equal mortality and incidence rates. The high liver 
cancer	rates	may	largely	be	explained	by	a	high	prevalence	
of chronic hepatitis B virus (HBV) infection. South-east 
Asia is considered a high endemicity area, in which about 
70-90% of the population becomes HBV-infected before 
the	age	of	40,	and	8	to	20%	of	people	are	HBV	carriers	
(Hollinger and Liang 2001).  HBV infections accounts for 
about	60%	of	the	total	liver	cancer	in	developing	countries	
and for about 23% of cancer in developed countries 
(Parkin	2006).
 
Colorectal cancer
 Colorectal cancer is the third most commonly 
diagnosed cancer in both males and females, with 
68,811	new	cancer	cases	and	44,280	deaths	estimated	to	
have	occurred	in	2008.	The	highest	 incidence	rates	per	
100,000	 are	 found	 in	Singapore	 (34.6),	Brunei	 (26.7),	
Malaysia	(17.5),	and	Indonesia	(17.2).	Rates	are	twofold	
of those in Vietnam (9.2), Thailand (13.3), Philippines 
(8.6)	and	Laos	(8.9).	Similarly,	mortality	rates	are	at	least	
twofold in Singapore (14.2), Brunei (13.4), Malaysia 
(11.5)	and	Indonesia	(12.9),	compared	to	Vietnam	(4.8),	
Thailand	(6.5),	Philippines	(3.9)	and	Laos	(5.4)	(Figure	
6).	Unfavourable,	 increased	 colorectal	 cancer	 rates	 are	
thought	to	reflect	changes	in	dietary	patterns,	obesity	and	
smoking rates, often seen in economically transitioning 
countries	(de	Kok	et	al.,	2008;	Center	et	al.,	2009).
 
Mouth and oropharynx cancer
	 Cancers	of	the	mouth	and	oropharynx	include	cancers	
of	the	lip	and	oral	cavity,	nasopharynx	and	other	pharynx	
cancers.	This	group	of	cancers	is	the	fifth	most	common	
in ASEAN, with an estimated 47,273 new cases and 
28,327	cancer	deaths	 in	2008.	 Incidence	 and	mortality	
rates	(per	100,000)	were	highest	in	Brunei	(17.4	and	7.6	
respectively) and Malaysia (12.9 and 7.1 respectively) and 
lowest	in	the	Philippines	(6.1	and	4.4	respectively)	and	
Vietnam	(6.4	and	4.7	respectively)	(Figure	7).	Mouth	and	
oropharynx	cancers	are	associated	with	environmental	and	
lifestyle risk factors, among which tobacco and alcohol 
play a major role. In addition to tobacco smoking, tobacco 
chewing is another risk factor as well as chewing betel 
quid and areca nut. Certain strains of virus, such as the 
Figure 5. Estimated Age-Standardised Mortality 
Rates (Per 100,000 Population) for Liver Cancer, by 
Country, in 2008
Figure 6. Estimated Age-Standardised Mortality Rates 
(Per 100,000 Population) for Colorectal Cancer, by 
Country, in 2008
Figure 7. Estimated Age-Standardised Mortality Rates 
(Per 100,000 Population) for Mouth and Oropharynx 
Cancer, by Country, in 2008
Figure 8. Estimated Age-Standardised Mortality rates 
(Per 100,000 Population) for Stomach Cancer, by 
Country, in 2008.
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sexually	transmitted	human	papilloma	virus,	also	play	a	
carcinogenic role (Lambert et al., 2011).
Stomach cancer
 Stomach is the seventh most commonly diagnosed 
cancer in ASEAN and the fourth leading cause of death, 
with	an	estimated	43,238	new	cases	and	35,320	cancer	
deaths	in	2008.	Incidence	rates	(per	100,000)	vary	from	as	
low as 4.2 in males and 3.0 in females in Thailand to a high 
24.4	in	males	and	14.6	in	females	in	Vietnam.	Mortality	
rates are highest in Vietnam, Cambodia and Myanmar 
(14.0,	8.4	and	9.0),	at	least	four	times	higher	than	rates	in	
Thailand	(2.5),	Laos	(3.4)	and	Philippines	(3.5)	(Figure	
8).	Regional	 variations	 in	 stomach	 cancer	 rates	 partly	
reflect	differences	in	the	prevalence	of	Helicobacter	pylori	
infection,	which	accounts	for	more	than	60%	of	stomach	
cancer	worldwide	(Parkin	2006;	Thun	et	al.,	2010).	
Breast cancer
 Breast cancer is the most frequently diagnosed cancer 
and the leading cause of cancer deaths in females in 
the ASEAN region, as well as worldwide. In ASEAN 
it accounts for 22% of the new (female) cancer cases 
and	15%	of	the	total	cancer	deaths	in	2008.	The	highest	
incidence	rate	per	100,000	is	found	in	Singapore	(59.9)	
and	 the	 lowest	 in	Vietnam	 (15.6).	Mortality	 rates	 per	
100,000,	however,	are	highest	in	Indonesia	(36.2),	quite	
low	in	Singapore	(13.6),	while	Vietnam	remains	on	the	
bottom of the ranking for breast cancer mortality (Figure 
9). In low- and middle-income countries in Southeast 
Asia, women are developing breast cancer at a relatively 
young	age	(under	50	years),	adding	enormous	pressure	
on families and societies (Institute for Health Metrics 
and Evaluation 2011). This trend is also apparent in the 
low-income countries within ASEAN, as illustrated by 
Figure 10. Factors that contribute to an increasing trend 
in breast cancer incidence among Asian women are not 
fully	understood,	but	thought	to	reflect	lifestyle	changes	
associated with westernization, including late child 
bearing, having fewer children, and consumption of 
calorie-dense food, physical inactivity and obesity (Jemal 
et al., 2010).
 
Cervical cancer
 Cervical cancer is the second most diagnosed cancer 
and the third leading cause of cancer death in females in 
ASEAN, accounting for 11% of the total new cancer cases 
and	9%	of	the	total	cancer	deaths	among	females	in	2008	
(Figure 11). Similar to breast cancer trends, the fraction of 
women	under	50	with	cervical	cancer	is	high	(see	Figure	
12).
 Cervical cancer incidence rates in Cambodia were 
almost	five	times	as	high	as	in	Singapore	(27.4	and	6.8	
per 100,000 respectively). Incidence rates were also 
very	high	in	Myanmar	(26.4),	Thailand	(24.5)	and	Laos	
(22.1). In Cambodia and Myanmar, cervical cancer has 
the	highest	mortality	rate	of	all	cancers	(16.2	and	15.0	per	
100,000 respectively). The high burden of cervical cancer 
in countries such as Cambodia, but also Myanmar and 
Thailand	(26.4	and	24.5	cases	per	100,000	respectively)	
appears to be due to a combination of factors including 
Figure 9. Estimated Age-Standardised Mortality Rates 
(Per 100,000 Female Population) for Breast Cancer, by 
Country, in 2008
Figure 10. Estimated Age-Specific Incidence Rates 
(Per 100,000 Female Population) for Breast Cancer, 
by Country, in 2008
Figure 11. Estimated Age-Standardised Mortality 
Rates (Per 100,000 Female Population) for Cervical 
Cancer, by Country, in 2008
Figure 12. Estimated Age-Specific Incidence Rates (Per 
100,000 Female Population) for Cervical Cancer, by 
Country, in 2008
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lack of widespread screening and treatment facilities, and 
a greater proportion of persistent Human papillomavirus 
(HPV)	 infections	 (Garland	 et	 al.,	 2008;	Mathew	 and	
George, 2009).  
Disability Adjusted Life Years (DALYs)
	 In	2008,	the	number	of	DALYs,	or	healthy	life	years,	
lost	to	cancer	in	ASEAN	was	7.5	million	of	which	48%	
was	lost	in	males	and	52%	in	females.	In	males,	liver	and	
lung cancers claimed most DALYs. In females, breast 
cancer	claimed	most	DALYs,	followed	by	cervix	and	lung	
cancers. 
 To compare between countries, age-standardised 
DALYs lost per 100,000 from all cancers by country 
are presented in Figure 13. The total burden of cancer is 
highest in Laos (1941 DALYs lost per 100,000), followed 
by	Vietnam	 (1863),	Myanmar	 (1853)	 and	 Indonesia	
(1841).	The	lowest	total	burden	of	cancer	is	found	in	the	
Philippines (1411) and Singapore (1492).These rankings 
largely	reflect	those	derived	on	the	basis	of	mortality.
Discussion
“As the prevalence of cancer continues to increase, 
it is imperative that we mobilise ASEAN member 
nations and encourage them to put in place a strategic, 
focussed cancer-control health care policy. This policy 
must be supported by organised, evidence-based cancer 
prevention programmes, and strengthened by reliable 
local patient registries and population databases,” said 
Dr Surin Pitsuwan, Secretary General of ASEAN, at a 
stakeholders meeting on the socio-economic burden of 
cancer in ASEAN communities, held in Singapore on the 
7th of July 2011 (Jan et al., 2012).
A first step towards a cancer control health care 
policy is an estimate of the burden of cancer at the 
population level, which is provided in this study, using 
well-established burden of disease measures. The data 
Figure 13. Burden of Cancer Expressed in Age-Standardised DALYs Lost (Per 100,000 Population), by Country, 
in 2008
provided in this study can be used as a benchmark to 
monitor change and for identifying priorities in cancer 
prevention and care (Lancet, 2010). 
Results show that there were over 700,000 new cases 
of	cancer	and	500,000	cancer	deaths	 in	ASEAN	in	 the	
year	2008,	leading	to	approximately	7.5	million	DALYs	
(i.e. healthy life years) lost in that year. The burden 
of cancer in terms of DALYs lost is highest in Laos, 
Vietnam and Myanmar and lowest in Brunei, Singapore 
and the Philippines. Furthermore, we found that high 
income countries (i.e. Singapore and Brunei) generally 
have higher breast, lung and colorectal cancer rates and 
low liver cancer rates, while low income countries (i.e. 
Myanmar, Laos and Cambodia) have higher cervical and 
stomach	cancer	rates.	Among	other	interesting	findings	
was a high rate of oesophagus cancer in Myanmar, with 
an	 age-standardised	 incidence	 rate	 of	 7.5	 per	 100,000,	
while all other countries have rates below 2 per 100,000. 
High	liver	cancer	incidence	rates	in	Laos	(33.8),	Thailand	
(29.7) and Vietnam (29.3) are also of concern. 
Results from this study are generally in line with 
several recent reviews (Jemal et al., 2010; Moore et al., 
2010a; 2010b), but this study differs in two respects; 
GLOBOCAN	 2008	 data	 was	 used	 (as	 opposed	 to	
GLOBOCAN 2002) and this study has added an estimation 
of the number of DALYs lost. An important difference 
between	 the	 2002	 and	2008	GLOBOCAN	data	 is	 that	
country-specific	 cancer	mortality	 estimates	 by	 sex	 and	
age group are now based on WHO mortality data, which, 
as well as being updated, have been corrected to take into 
account incompleteness or under-coverage (Ferlay et al., 
2010). The global burden of disease 2004 update by WHO 
also reports DALY estimations for cancer (Mathers et al., 
2008).	However,	WHO’s	DALY	estimations	and	estimates	
found in this study cannot be reliably compared since the 
GBD 2004 update used incidence data from GLOBOCAN 
2002 and mortality data from other sources. 
Differences in lifestyle-related factors contribute to 
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regional differences in cancer rates, as well as access to 
screening	programs	and	vaccines	(Boyle	et	al.,	2008).	The	
continuing	growth	and	ageing	of	ASEAN’s	population,	
their increasing wealth, changes in lifestyle, and pre-
existing	 factors	 (especially	 cancer-related	 infections)	
mean that the burden of cancer will continue to increase 
(Mathers	 et	 al.,	 2008).	A	 significant	 proportion	 of	 this	
burden of cancer could be prevented through the use of 
existing	cancer	control	knowledge,	and	by	implementing	
programs for tobacco control, vaccination (for liver and 
cervical cancers), and early detection and treatment, 
as well as public health campaigns promoting physical 
activity	and	healthier	dietary	patterns	(Boyle	et	al.,	2008).	
Targeted prevention and treatment strategies aimed at 
preventable forms of cancer not only could save lives, but 
also improve economic development prospects in ASEAN.
The strength of our study is the use of cancer registry 
data	 collected	 in	GLOBOCAN	2008	 (Lancet,	 2010).	
However, estimates in GLOBOCAN are variable in 
accuracy,	depending	on	the	extent	and	validity	of	available	
data by country, ranging from real and valid counts of 
cases and deaths, to estimates based on samples, through 
those based on rates in neighbouring countries. Incidence 
data for most ASEAN countries were limited by their 
geographic coverage; therefore the estimates of cancer 
burden that were derived for a number of ASEAN countries 
were	based	on	extrapolation.	For	example,	estimates	for	
Laos and Myanmar were based on incidence and mortality 
estimates from neighbouring countries (mainly Thailand) 
which	were	then	applied	to	country-specific	demographic	
data. Despite concern regarding the data quality and 
the	methods	of	estimation,	the	GLOBOCAN	2008	data	
represent the best available, and an unbiased, source of 
information	on	the	profile	of	cancer.
The addition of DALY estimations in this study 
provides	 a	 first	 indication	 of	 the	 burden	 of	 cancer	 in	
ASEAN countries. Nevertheless, for our estimations we 
used uniform survival rates across all low- and middle-
income countries in ASEAN and thereby under-estimating 
between-country differences in cancer burden (Pisani 
et al., 1999). We also assumed no long term disability, 
although there are some cancers that are likely to have 
major sequelae causing long-term burden following 
successful treatment, such as breast and colorectal cancers. 
This assumption will have led to an underestimation 
of DALYs lost; however, due to poor survival rates, 
premature mortality remains the major component of the 
DALY in low- and middle-income countries and thus this 
disability assumption is unlikely to be a major source of 
error.
The limitations of the GLOBOCAN data emphasize 
the need for population-based cancer registries. Accurate 
national incidence and mortality data is necessary to 
monitor status and change, investigate success of cancer 
control activities, and help in decision making (Valsecchi 
and	Steliarova-Foucher,	2008).	Better	information	on	the	
severity and duration of the disease is also essential to 
improve	estimates	of	the	extent	of	the	cancer	burden	and	to	
gauge its relative contribution to overall burden of disease. 
As an important step in addressing this, the ASEAN 
Foundation, together with The George Institute for Global 
Health and Roche are undertaking an observational study 
of 10,000 newly diagnosed patients with cancer within 
the ASEAN region. The ACTION study (Asean CosTs 
In ONcology) will assess, in each country, the impact of 
cancer on quality of life and the economic circumstances 
of patients and their households (Kimman et al., 2012). 
Local data from the ACTION study can be used to revise 
the initial estimates from this burden of cancer study, and 
combined with data on cost, result in better estimates of 
the economic burden.
In conclusion, the present study provides a snapshot 
of	cancer	burden	in	ASEAN.	A	key	finding,	as	reflected	in	
the effect of the age-standardisation procedure on disease 
burden estimates, is the major impact played by population 
age distribution on cancer incidence and mortality. Whilst 
many	of	the	factors	that	will	influence	the	epidemiology	
of cancer in this region over coming years such as the 
effectiveness of new health technologies and programs 
are uncertain, we can be sure that most, if not all of these 
countries will undergo some degree of economic growth, 
and with it, an ageing of their populations and increase in 
the	burden	of	cancer	(Kanavos	2006;	Thun	et	al.,	2010).	
Policy and funding priorities in each of these countries 
must therefore be geared toward dealing with this trend by 
planning for the strengthening of health systems to cope 
with projected increases in cancer prevention, treatment 
and management needs.
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